Related Experiment Video
Updated: Jun 14, 2026
09:11
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Hyperbranched poly(amine-ester) based hydrogels for controlled multi-drug release in combination chemotherapy.
Hongbin Zhang1, Chen Zhao, Hui Cao
1School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China.
Biomaterials
|April 13, 2010
Summary
Injectable hyperbranched poly(amine-ester) hydrogels offer a novel multi-drug delivery system for cancer chemotherapy. These biocompatible hydrogels enable controlled, localized release of multiple anticancer drugs, enhancing treatment efficacy.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Combination chemotherapy is a cornerstone of cancer treatment.
- A need exists for sophisticated drug delivery systems capable of simultaneous administration and controlled release of multiple anticancer agents.
- Injectable hydrogels offer potential for localized and sustained drug delivery.
Purpose of the Study:
- To synthesize injectable hyperbranched poly(amine-ester) (HPAE) macromers for use as a multi-drug delivery system.
- To investigate the hydrogel formation, drug release kinetics, and biocompatibility of the synthesized HPAE systems.
- To evaluate the potential of HPAE hydrogels for localized delivery of single and/or multiple anticancer drugs.
Main Methods:
- Synthesis of HPAE macromers with varying degrees of terminal CC modification.
- Formation of injectable hydrogels at body temperature using a redox initiation system (HPAE macromer and ammonium persulfate).
- Loading and in vitro release studies of model anticancer drugs (doxorubicin hydrochloride, 5-fluorouracil, leucovorin calcium).
- Evaluation of HPAE hydrogel biocompatibility using MTT assay on L929 and MCF7 cell lines.
- In vitro assessment of hydrogel swelling and degradation behavior.
Main Results:
- Injectable HPAE hydrogels formed rapidly at body temperature from low-concentration macromer solutions.
- Drug release profiles were controllable via drug-loading methods and CC modification degree, with higher CC content prolonging release.
- HPAE macromers demonstrated good biocompatibility in L929 and MCF7 cell lines.
- In vitro swelling and degradation studies confirmed the hydrogels' stability and behavior.
- Simultaneous release of single and/or multiple anticancer drugs was achieved in a controlled manner.
Conclusions:
- HPAE macromers can form injectable hydrogels suitable for multi-drug delivery.
- The developed system allows for tunable and localized release of anticancer drugs.
- These HPAE hydrogels show significant promise as advanced delivery platforms for cancer chemotherapy.
More Related Videos
15:33Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...